Dr. Bahija Jallal is a Chief Executive Officer & Director at Immunocore Holdings Plc, an Independent Director at Elevance Health, Inc., a Chief Executive Officer & Director at Immunocore Ltd. and a Council Member at National Academies of Sciences.

She is on the Board of Directors at Arrivent Biopharma, Inc., Immunocore Holdings Plc, Elevance Health, Inc., Immunocore Ltd., Umb Health Sciences Research Park Corp. and The Johns Hopkins University. Dr. Jallal was previously employed as an Independent Director by Guardant Health, Inc., a President by Association for Women in Science, an Executive Vice President by AstraZeneca Plc, a President by MedImmune LLC, a Vice President-Drug Assessment & Development by Chiron Corp., and a Non-Executive Director by ADC Therapeutics SA.

She also served on the board at Viela Bio, Inc.